• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于美国癌症联合委员会第八版癌症分期系统的预后分期组对三阴性乳腺癌预后意义的验证:来自监测、流行病学和最终结果 18 数据库的分析。

Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.

机构信息

Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Department of Orthopedics, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

J Surg Res. 2020 Mar;247:211-219. doi: 10.1016/j.jss.2019.09.072. Epub 2019 Nov 6.

DOI:10.1016/j.jss.2019.09.072
PMID:31706539
Abstract

BACKGROUND

The eighth edition of the American Cancer Joint Committee on Cancer (AJCC) staging system for breast cancer put forward the prognostic stage groups for the first time based on the traditional anatomic tumor-node-metastasis staging system. Our study intends to validate the predictive significance of the eighth edition staging system in triple-negative breast cancer (TNBC) patients.

MATERIALS AND METHODS

We collected and accessed 26,589 eligible cases of TNBC from the Surveillance, Epidemiology, and End Results database (2010-2015) and reclassified the patient cohort according to the eighth edition of the AJCC staging system into anatomic and prognostic stages.

RESULTS

The results showed that more than half of the patients upstaged in the prognostic stage when compared with the anatomic stage. By comparing with the anatomic stage, the prognostic stage had a higher likelihood ratio and linear trend χ values. The prognostic stage group also had higher Akaike information criterion and Bayesian information criterion values than the anatomic stage group.

CONCLUSIONS

The prognostic staging system in TNBC patients performs more optimistic prognostic stratification and predictability than the anatomic staging system. Moreover, the latest AJCC staging system has a milestone importance to the history of breast cancer staging system.

摘要

背景

第八版美国癌症联合委员会癌症分期系统(AJCC)首次提出了基于传统解剖学肿瘤-淋巴结-转移分期系统的预后分期组。本研究旨在验证第八版分期系统在三阴性乳腺癌(TNBC)患者中的预测意义。

材料和方法

我们从监测、流行病学和最终结果数据库(2010-2015 年)中收集并获取了 26589 例符合条件的 TNBC 患者,并根据第八版 AJCC 分期系统将患者队列重新分类为解剖学和预后分期。

结果

结果显示,与解剖学分期相比,预后分期中有超过一半的患者分期升高。与解剖学分期相比,预后分期具有更高的似然比和线性趋势 χ 值。预后分期组的 Akaike 信息准则和贝叶斯信息准则值也高于解剖学分期组。

结论

TNBC 患者的预后分期系统比解剖学分期系统具有更乐观的预后分层和预测能力。此外,最新的 AJCC 分期系统对乳腺癌分期系统的历史具有里程碑意义。

相似文献

1
Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.基于美国癌症联合委员会第八版癌症分期系统的预后分期组对三阴性乳腺癌预后意义的验证:来自监测、流行病学和最终结果 18 数据库的分析。
J Surg Res. 2020 Mar;247:211-219. doi: 10.1016/j.jss.2019.09.072. Epub 2019 Nov 6.
2
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.基于人群的分析:将复发评分纳入美国癌症联合委员会第八版 T1-2N0M0、雌激素受体阳性、人表皮生长因子受体 2 阴性浸润性乳腺癌患者分期系统的评估。
Oncologist. 2019 Nov;24(11):e1014-e1023. doi: 10.1634/theoncologist.2018-0727. Epub 2019 Apr 24.
3
The predictive value of the prognostic staging system in the 8th edition of the American Joint Committee on Cancer for triple-negative breast cancer: a SEER population-based analysis.第 8 版美国癌症联合委员会预后分期系统对三阴性乳腺癌的预测价值:一项 SEER 基于人群的分析。
Future Oncol. 2019 Feb;15(4):391-400. doi: 10.2217/fon-2018-0145. Epub 2019 Jan 8.
4
The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.根据第 8 版 AJCC 对日本乳腺癌患者预后的解剖分期和病理预后分期比较:单机构数据。
Breast Cancer. 2020 Nov;27(6):1137-1146. doi: 10.1007/s12282-020-01116-w. Epub 2020 May 29.
5
Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.第八版美国癌症联合委员会肿瘤分期系统在局部晚期乳腺癌中的预后评估:基于 SEER18 数据库的分析。
Breast. 2018 Feb;37:56-63. doi: 10.1016/j.breast.2017.10.011. Epub 2017 Oct 31.
6
Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.更新后的美国癌症联合委员会(AJCC)乳腺癌病理预后分期在更高分期组中,其预后预测得到了改善,但存在差异。
Clin Breast Cancer. 2020 Jun;20(3):253-261.e7. doi: 10.1016/j.clbc.2020.01.011. Epub 2020 Mar 20.
7
Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.验证修订版第八版 AJCC 分期手册中不同乳腺癌分子亚型的病理预后分期系统。
Virchows Arch. 2019 Feb;474(2):193-200. doi: 10.1007/s00428-018-2495-x. Epub 2018 Nov 24.
8
The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.第8版美国癌症联合委员会(AJCC)乳腺癌预后分期系统及简化分期系统的评估:来自监测、流行病学和最终结果(SEER)数据库的分析结果
Breast J. 2019 Sep;25(5):838-847. doi: 10.1111/tbj.13347. Epub 2019 Jun 13.
9
Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.预测甲状腺乳头状癌患者的生存情况:在两个当代国家患者队列中比较第七版和第八版美国癌症联合委员会/国际癌症控制联合会分期系统。
Thyroid. 2017 Nov;27(11):1408-1416. doi: 10.1089/thy.2017.0306. Epub 2017 Oct 5.
10
Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.AJCC 解剖学和临床预后分期组在乳腺癌中的比较:单中心 3322 例分析。
Clin Breast Cancer. 2018 Dec;18(6):e1347-e1352. doi: 10.1016/j.clbc.2018.07.013. Epub 2018 Jul 17.

引用本文的文献

1
SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer.基于SNAP标签的重组光免疫治疗剂,用于选择性检测和杀伤可光接触的表达黑素转铁蛋白的黑色素瘤和三阴性乳腺癌。
Cancer Med. 2025 May;14(9):e70912. doi: 10.1002/cam4.70912.
2
Exploration of Traditional Chinese Medicine Comprehensive Treatment of Triple Negative Breast Cancer Based on Molecular Pathological Mechanism.基于分子病理机制的中医综合治疗三阴性乳腺癌探索
Breast Cancer (Dove Med Press). 2025 Apr 10;17:289-304. doi: 10.2147/BCTT.S511059. eCollection 2025.
3
Differences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular Classification.
根据免疫组织化学分子分类的浸润性小叶乳腺癌组织学亚型差异
Diagnostics (Basel). 2024 Mar 21;14(6):660. doi: 10.3390/diagnostics14060660.
4
PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy.PAK抑制剂FRAX486通过阻断自噬降低三阴性乳腺癌细胞的转移潜能。
Br J Cancer. 2024 Feb;130(3):394-405. doi: 10.1038/s41416-023-02523-4. Epub 2023 Dec 18.
5
[JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA MALAT1 in exosomes].[JAG1通过外泌体中的LncRNA MALAT1影响单核细胞-巨噬细胞重塑三阴性乳腺癌的前转移微环境]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Sep 20;43(9):1525-1535. doi: 10.12122/j.issn.1673-4254.2023.09.10.
6
Combination of Anatomical and Biological Factors to Predict Disease-Free Survival in Breast Cancer.联合解剖学和生物学因素预测乳腺癌无病生存。
JCO Glob Oncol. 2023 Mar;9:e2200269. doi: 10.1200/GO.22.00269.
7
Stage-Specific Survival in Breast Cancer in Chinese and White Women: Comparative Data Analysis.中国和白人女性乳腺癌的特定分期生存比较:数据分析。
JMIR Public Health Surveill. 2022 Nov 15;8(11):e40386. doi: 10.2196/40386.
8
Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.铂类药物与非铂类药物治疗三阴性乳腺癌的疗效:荟萃分析。
Eur J Med Res. 2022 Oct 15;27(1):201. doi: 10.1186/s40001-022-00839-0.
9
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer.持续的表皮生长因子受体/ Kirsten 大鼠肉瘤病毒癌基因同源物/七分子相互作用蛋白通路激活驱动三阴性乳腺癌的化疗耐药和早期肿瘤复发。
Cancer Drug Resist. 2022 Jun 22;5(3):691-702. doi: 10.20517/cdr.2022.31. eCollection 2022.
10
Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing.通过靶向二代测序分析突变作为大肠锯齿状息肉复发的潜在预测指标
Front Oncol. 2022 Mar 23;12:769709. doi: 10.3389/fonc.2022.769709. eCollection 2022.